Rare diseases
Investigational molecules
Locations
Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease
BelgiumStudy of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis
BelgiumStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
BelgiumStudy of felzartamab compared to placebo in adults with IgA nephropathy
BelgiumStudy of MK-2214 to slow disease progression in people with early Alzheimer's disease
BelgiumStudy of zolbetuximab combined with paclitaxel and ramucirumab for patients with previously treated CLDN18.
BelgiumStudy of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis
BelgiumStudy of NVD003 stem cell implant compared to bone graft for children with congenital pseudarthrosis of the tibia
BelgiumStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
BelgiumStudy of Lutetium-177-PSMA treatment for patients with advanced clear cell kidney cancer who had progression after first or second line therapy
BelgiumStudy of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression
BelgiumStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
